Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Janssen-Cilag Limited, 50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK
For the treatment of mycotic vulvovaginitis and mycotic balanitis.
For vaginal/penile administration.
Females: One applicator full (approximately 5 g) intravaginally once daily at night for not less than 14 days. The cream should also be applied to the vulva. The full 14 days treatment should be carried out even if the symptoms of vaginal itching or discharge have disappeared.
In pregnant women, it is recommended that administration takes place without the use of an applicator, or is performed by a physician. Pregnant women should thoroughly wash their hands before self-administering Gyno-Pevaryl cream.
Males: Apply the cream to the penis, including under the foreskin, once daily for not less than 14 days.
The sexual partner should also be treated.
Adverse events associated with overdose or misuse of Gyno-Pevaryl Cream are expected to be consistent with adverse drug reactions already listed in Section 4.8. (Undesirable effects).
In the event of accidental ingestion, nausea, vomiting and diarrhoea may occur. If necessary treat symptomatically.
If the product is accidentally applied to the eyes, wash with clean water or saline and seek medical attention if symptoms persist.
24 months.
Do not store above 25°C.
Aluminium lacquered tubes.
Pack sizes 78 g, 30g, 15g.
None stated.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.